⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11294909 | 1.00 | — | — | |
| SCHEMBL19733091 | 1.00 | — | — | |
| SCHEMBL8080701 | 1.00 | — | — | |
| SCHEMBL438 | 1.00 | — | — | |
| SCHEMBL8466582 | 1.00 | — | — | |
| SCHEMBL121426 | 1.00 | — | — | |
| SCHEMBL5509125 | 1.00 | — | — | |
| SCHEMBL5505569 | 1.00 | — | — | |
| SCHEMBL29364902 | 1.00 | — | — | |
| Water SCHEMBL6118960 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025026740-A1 | METHOD AND DEVICE FOR CHARACTERISING THE ELEMENTARY COMPOSITION OF A SAMPLE, BY NEUTRON ACTIVATION | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2025-02-06 | — | — | WO | disclosed |
| CN-111170991-B | Antiproliferative compounds and methods of synthesis thereof | 细胞基因公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116768882-A | Compounds, pharmaceutical compositions and methods of treatment | 奥斯拜客斯制药有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-116437914-A | Glucokinase activators for the treatment of diabetes with liver injury | 华领医药技术（上海）有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-109476600-B | Pyridinethione, pharmaceutical compositions thereof and therapeutic use thereof for the treatment of proliferative, inflammatory, neurodegenerative or immune-mediated diseases | 纽罗赛里克斯加拿大有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-115282149-A | Treatment of hematologic malignancies with anticancer agents | 细胞基因公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-114788824-A | Deutetrabenazine, or compositions comprising deutetrabenazine | 奥斯拜客斯制药有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-114767672-A | Deutetrabenazine, or compositions comprising deutetrabenazine | 奥斯拜客斯制药有限公司 | 2022-07-22 | — | — | CN | disclosed |